CSL's Chief Since 1990 To Retire, CSL Behring Chief To Assume Role
This article was originally published in PharmAsia News
Executive Summary
Brian McNamee, the only head of Australia's CSL since it was a government entity in 1990, announced his intention to retire in July.
Brian McNamee, the only head of Australia's CSL since it was a government entity in 1990, announced his intention to retire in July. Paul Perreault, now head of CSL Behring, has been tapped to replace McNamee as head of the major immunoglobin manufacturer. Under McNamee, CSL has become Australia's largest pharmaceutical company, which reported a net profit of $627 million in the last half of 2012. Immunoglobulin sales grew 10% to $912 million in the first half of the fiscal year. (Click here for more
)
"McNamee Leaving CSL With Healthy Bottom Line" - Canberra Times (Australia) (2/14/2013)